Yang Ok, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, Dai Z, Zhang X, Zhang L, Peng Y, Ye W, Zeng W, Liu Z, Cheng Q. Glioma focused remedy: perception into way forward for molecular approaches. Mol Most cancers. 2022;21:39.
Zhou Q, Xue C, Ke X, Zhou J. Therapy response and prognosis analysis in high-grade glioma: an imaging assessment primarily based on MRI. J Magn Reson Imaging. 2022;56:325–40.
Ho RLY, Ho IAW. Current advances in glioma remedy: combining vascular normalization and immune checkpoint blockade. Cancers (Basel). 2021;13:3686.
Takacs GP, Flores-Toro JA, Harrison JK. Modulation of the chemokine/chemokine receptor axis as a novel strategy for glioma remedy. Pharmacol Ther. 2021;222:107790.
Tamai S, Ichinose T, Tsutsui T, Tanaka S, Garaeva F, Sabit H, Nakada M. Tumor microenvironment in glioma invasion. Mind Sci. 2022;12:505.
Li X, Geng X, Chen Z, Yuan Z. Current advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy. Pharmacol Res. 2022;179:106218.
Kim PL. Concentrating on gene fusions in glioma. Curr Opin Neurol. 2021;34:840–7.
Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Positive U, Thakur BK, Hetze S. Glioma: molecular signature and crossroads with tumor microenvironment. Most cancers Metastasis Rev. 2022;41:53–75.
Xia X, Wang Y, Qin Y, Zhao S, Zheng JC. Exosome: a novel neurotransmission modulator or non-canonical neurotransmitter? Ageing Res Rev. 2022;74:101558.
Yu W, Hurley J, Roberts D, Chakrabortty SK, Enderle D, Noerholm M, Breakefield XO, Skog JK. Exosome-based liquid biopsies in most cancers: alternatives and challenges. Ann Oncol. 2021;32:466–77.
Li MY, Liu LZ, Dong M. Progress on pivotal function and software of exosome in lung most cancers carcinogenesis, analysis, remedy and prognosis. Mol Most cancers. 2021;20:22.
Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-mediated metastasis: communication from a distance. Dev Cell. 2019;49:347–60.
Ranjbaran A, Latifi Z, Nejabati HR, Abroon S, Mihanfar A, Sadigh AR, Fattahi A, Nouri M, Raffel N. Exosome-based intercellular communication in feminine reproductive microenvironments. J Cell Physiol. 2019;234:19212–22.
Wan Z, Gao X, Dong Y, Zhao Y, Chen X, Yang G, Liu L. Exosome-mediated cell-cell communication in tumor development. Am J Most cancers Res. 2018;8:1661–73.
Solar Z, Yang S, Zhou Q, Wang G, Music J, Li Z, Zhang Z, Xu J, Xia Ok, Chang Y, Liu J, Yuan W. Rising function of exosome-derived lengthy non-coding RNAs in tumor microenvironment. Mol Most cancers. 2018;17:82.
Kim H, Jang H, Cho H, Choi J, Hwang KY, Choi Y, Kim SH, Yang Y. Current advances in exosome-based drug supply for most cancers remedy. Cancers (Basel). 2021;13:4435.
Pathania AS, Prathipati P, Challagundla KB. New insights into exosome mediated tumor-immune escape: medical views and therapeutic methods. Biochim Biophys Acta Rev Most cancers. 2021;1876:188624.
Santos P, Almeida F. Exosome-based vaccines: historical past, present state, and medical trials. Entrance Immunol. 2021;12:711565.
Noonin C, Thongboonkerd V. Exosome-inflammasome crosstalk and their roles in inflammatory responses. Theranostics. 2021;11:4436–51.
Han C, Zhang C, Wang H, Zhao L. Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment. Oncoimmunology. 2021;10:1887552.
Duan L, Xu L, Xu X, Qin Z, Zhou X, Xiao Y, Liang Y, Xia J. Exosome-mediated supply of gene vectors for gene remedy. Nanoscale. 2021;13:1387–97.
Yousafzai NA, Wang H, Wang Z, Zhu Y, Zhu L, Jin H, Wang X. Exosome mediated multidrug resistance in most cancers. Am J Most cancers Res. 2018;8:2210–26.
Wang B, Tan Z, Guan F. Tumor-derived exosomes mediate the instability of cadherins and promote tumor development. Int J Mol Sci. 2019;20:3652.
Wan M, Ning B, Spiegel S, Lyon CJ, Hu TY. Tumor-derived exosomes (TDEs): find out how to keep away from the sting within the tail. Med Res Rev. 2020;40:385–412.
Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Evaluate of the isolation, characterization, organic perform, and multifarious therapeutic approaches of exosomes. Cells. 2019;8:307.
Shenoy GN, Bhatta M, Bankert RB. Tumor-associated exosomes: a possible therapeutic goal for restoring anti-tumor T cell responses in human tumor microenvironments. Cells. 2021;10:3155.
Whiteside TL, Diergaarde B, Hong CS. Tumor-derived exosomes (TEX) and their function in immuno-oncology. Int J Mol Sci. 2021;22:6234.
McAndrews KM, Kalluri R. Mechanisms related to biogenesis of exosomes in most cancers. Mol Most cancers. 2019;18:52.
Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the rising function in tumor microenvironment reworking and its affect on most cancers development. Sign Transduct Goal Ther. 2020;5:242.
Wu Q, Zhou L, Lv D, Zhu X, Tang H. Exosome-mediated communication within the tumor microenvironment contributes to hepatocellular carcinoma growth and development. J Hematol Oncol. 2019;12:53.
Liu J, Wu F, Zhou H. Macrophage-derived exosomes in cancers: biogenesis, features and therapeutic functions. Immunol Lett. 2020;227:102–8.
Fraga de Andrade I, Mehta C, Bresnick EH. Submit-transcriptional management of mobile differentiation by the RNA exosome advanced. Nucleic Acids Res. 2020;48:11913–28.
Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a assessment of its classification, isolation methods, storage, diagnostic and focused remedy functions. Int J Nanomed. 2020;15:6917–34.
Agarwal S, Agarwal V, Agarwal M, Singh M. Exosomes: construction biogenesis, sorts and software in analysis and gene and drug supply. Curr Gene Ther. 2020;20:195–206.
Shan X, Zhang C, Mai C, Hu X, Cheng N, Chen W, Peng D, Wang L, Ji Z, Xie Y. The biogenesis organic features, and functions of macrophage-derived exosomes. Entrance Mol Biosci. 2021;8:715461.
Kalluri R, LeBleu VS. The biology, perform, and biomedical functions of exosomes. Science. 2020;367:eaau977.
Yue B, Yang H, Wang J, Ru W, Wu J, Huang Y, Lan X, Lei C, Chen H. Exosome biogenesis, secretion and performance of exosomal miRNAs in skeletal muscle myogenesis. Cell Prolif. 2020;53:e12857.
Kumar A, Deep G. Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational alternatives. Most cancers Lett. 2020;479:23–30.
Boriachek Ok, Islam MN, Möller A, Salomon C, Nguyen NT, Hossain MSA, Yamauchi Y, Shiddiky MJA. Organic features and present advances in isolation and detection methods for exosome nanovesicles. Small. 2018;14:1702153.
Hessvik NP, Llorente A. Present data on exosome biogenesis and launch. Cell Mol Life Sci. 2018;75:193–208.
He G, Peng X, Wei S, Yang S, Li X, Huang M, Tang S, Jin H, Liu J, Zhang S, Zheng H, Fan Q, Liu J, Yang L, Li H. Exosomes within the hypoxic TME: from launch, uptake and biofunctions to medical functions. Mol Most cancers. 2022;21:19.
Farooqi AA, Desai NN, Qureshi MZ, Librelotto DRN, Gasparri ML, Bishayee A, Nabavi SM, Curti V, Daglia M. Exosome biogenesis, bioactivities and features as new supply programs of pure compounds. Biotechnol Adv. 2018;36:328–34.
Syn N, Wang L, Sethi G, Thiery JP, Goh BC. Exosome-mediated metastasis: from epithelial-mesenchymal transition to flee from immunosurveillance. Traits Pharmacol Sci. 2016;37:606–17.
Xie S, Zhang Q, Jiang L. Present data on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes (Basel). 2022;12:498.
Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Sign. 2021;19:47.
Nicolini A, Ferrari P, Biava PM. Exosomes and cell communication: from tumour-derived exosomes and their function in tumour development to using exosomal cargo for most cancers therapy. Cancers (Basel). 2021;13:822.
Daßler-Plenker J, Küttner V, Egeblad M. Communication in tiny packages: exosomes as technique of tumor-stroma communication. Biochim Biophys Acta Rev Most cancers. 2020;1873:188340.
Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic perform and medical potential. Cell Biosci. 2019;9:19.
Kahroba H, Hejazi MS, Samadi N. Exosomes: from carcinogenesis and metastasis to analysis and therapy of gastric most cancers. Cell Mol Life Sci. 2019;76:1747–58.
Fanale D, Taverna S, Russo A, Bazan V. Round RNA in exosomes. Adv Exp Med Biol. 2018;1087:109–17.
Colletti M, Ceglie D, Di Giannatale A, Nazio F. Autophagy and exosomes relationship in most cancers: associates or foes? Entrance Cell Dev Biol. 2020;8:614178.
Sinha D, Roy S, Saha P, Chatterjee N, Bishayee A. Traits in analysis on exosomes in most cancers development and anticancer remedy. Cancers (Basel). 2021;13:326.
Romano E, Netti PA, Torino E. Exosomes in gliomas: biogenesis, isolation, and preliminary functions in nanomedicine. Prescription drugs (Basel). 2020;13:319.
Tang Z, Li D, Hou S, Zhu X. The most cancers exosomes: medical implications, functions and challenges. Int J Most cancers. 2020;146:2946–59.
Jabbari N, Karimipour M, Khaksar M, Akbariazar E, Heidarzadeh M, Mojarad B, Aftab H, Rahbarghazi R, Rezaie J. Tumor-derived extracellular vesicles: insights into bystander results of exosomes after irradiation. Lasers Med Sci. 2020;35:531–45.
Stahl PD, Raposo G. Exosomes and extracellular vesicles: the trail ahead. Essays Biochem. 2018;62:119–24.
Huang T, Deng CX. Present progresses of exosomes as most cancers diagnostic and prognostic biomarkers. Int J Biol Sci. 2019;15:1–11.
Gao D, Jiang L. Exosomes in most cancers remedy: a novel experimental technique. Am J Most cancers Res. 2018;8:2165–75.
Mousavi S, Moallem R, Hassanian SM, Sadeghzade M, Mardani R, Ferns GA, Khazaei M, Avan A. Tumor-derived exosomes: potential biomarkers and therapeutic goal within the therapy of colorectal most cancers. J Cell Physiol. 2019;234:12422–32.
Jella KK, Nasti TH, Li Z, Malla SR, Buchwald ZS, Khan MK. Exosomes, their biogenesis and function in inter-cellular communication, tumor microenvironment and most cancers immunotherapy. Vaccines (Basel). 2018;6:69.
Samanta S, Rajasingh S, Drosos N, Zhou Z, Daybreak B, Rajasingh J. Exosomes: new molecular targets of illnesses. Acta Pharmacol Sin. 2018;39:501–13.
Wang Q, Zhang C, Cao S, Zhao H, Jiang R, Li Y. Tumor-derived exosomes orchestrate the microRNA-128–3p/ELF4/CDX2 axis to facilitate the expansion and metastasis of gastric most cancers by way of supply of LINC01091. Cell Biol Toxicol. 2022. https://doi.org/10.1007/s10565-022-09728-y.
Chatterjee S, Chatterjee A, Jana S, Dey S, Roy H, Das MK, Alam J, Adhikary A, Chowdhury A, Biswas A, Manna D, Bhattacharyya A. Reworking progress issue beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast most cancers. Carcinogenesis. 2021;42:38–47.
Liu H, Chen W, Zhi X, Chen EJ, Wei T, Zhang J, Shen J, Hu LQ, Zhao B, Feng XH, Bai XL, Liang TB. Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to boost cell motility. Oncogene. 2018;37:4964–78.
Jia Z, Jia J, Yao L, Li Z. Crosstalk of exosomal non-coding RNAs within the tumor microenvironment: novel frontiers. Entrance Immunol. 2022;13:900155.
Jing X, Xie M, Ding Ok, Xu T, Fang Y, Ma P, Shu Y. Exosome-transmitted miR-769-5p confers cisplatin resistance and development in gastric most cancers by focusing on CASP9 and selling the ubiquitination degradation of p53. Clin Transl Med. 2022;12:e780.
Li Y, Zhao W, Wang Y, Wang H, Liu S. Extracellular vesicle-mediated crosstalk between pancreatic most cancers and stromal cells within the tumor microenvironment. J Nanobiotechnol. 2022;20:208.
Thakur A, Johnson A, Jacobs E, Zhang Ok, Chen J, Wei Z, Lian Q, Chen HJ. Vitality sources for exosome communication in a most cancers microenvironment. Cancers (Basel). 2022;14:1698.
Xu Y, Feng Ok, Zhao H, Di L, Wang L, Wang R. Tumor-derived extracellular vesicles as messengers of pure merchandise in most cancers therapy. Theranostics. 2022;12:1683–714.
Attaran S, Bissell MJ. The function of tumor microenvironment and exosomes in dormancy and relapse. Semin Most cancers Biol. 2022;78:35–44.
Bondhopadhyay B, Sisodiya S, Alzahrani FA, Bakhrebah MA, Chikara A, Kasherwal V, Khan A, Rani J, Dar SA, Akhter N, Tanwar P, Agrawal U, Hussain S. Exosomes: a forthcoming period of breast most cancers therapeutics. Cancers (Basel). 2021;13:4672.
Vautrot V, Bentayeb H, Causse S, Garrido C, Gobbo J. Tumor-derived exosomes: hidden gamers in PD-1/PD-L1 resistance. Cancers (Basel). 2021;13:4537.
Jiang C, Zhang N, Hu X, Wang H. Tumor-associated exosomes promote lung most cancers metastasis via a number of mechanisms. Mol Most cancers. 2021;20:117.
Zhang G, Zhang Y, Cheng S, Wu Z, Liu F, Zhang J. CD133 optimistic U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment. J Neurooncol. 2017;135:37–46.
Wang M, Jia J, Cui Y, Peng Y, Jiang Y. CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal enlargement. Cell Demise Dis. 2021;12:1065.
Guo X, Qiu W, Liu Q, Qian M, Wang S, Zhang Z, Gao X, Chen Z, Xue H, Li G. Immunosuppressive results of hypoxia-induced glioma exosomes via myeloid-derived suppressor cells by way of the miR-10a/Rora and miR-21/Pten Pathways. Oncogene. 2018;37:4239–59.
Cao TH, Ling X, Chen C, Tang W, Hu DM, Yin GJ. Position of miR-214-5p within the migration and invasion of pancreatic most cancers cells. Eur Rev Med Pharmacol Sci. 2018;22(21):7214–21. https://doi.org/10.26355/eurrev_201811_16255.
Gong F, Chai W, Wang J, Cheng H, Shi Y, Cui L, Jia G. miR-214-5p suppresses the proliferation, migration and invasion of trophoblast cells in pre-eclampsia by focusing on jagged 1 to inhibit the notch signaling pathway. Acta Histochem. 2020;122(3):151527. https://doi.org/10.1016/j.acthis.2020.151527.
Yang JK, Liu HJ, Wang Y, Li C, Yang JP, Yang L, Qi XJ, Zhao YL, Shi XF, Li JC, Solar GZ, Jiao BH. Exosomal miR-214-5p launched from glioblastoma cells modulates inflammatory response of microglia after lipopolysaccharide stimulation via focusing on CXCR5. CNS Neurol Disord Drug Targets. 2019;18:78–87.
Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W, Gao X, Chen Z, Xu J, Zhao R, Xue H, Li G. Hypoxic glioma-derived exosomes ship microRNA-1246 to induce M2 macrophage polarization by focusing on TERF2IP by way of the STAT3 and NF-κB pathways. Oncogene. 2020;39:428–42.
Xu J, Zhang J, Zhang Z, Gao Z, Qi Y, Qiu W, Pan Z, Guo Q, Li B, Zhao S, Guo X, Qian M, Chen Z, Wang S, Gao X, Zhang S, Wang H, Guo X, Zhang P, Zhao R, Xue H, Li G. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Demise Dis. 2021;12:373.
Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, Zhang S, Zhao S, Xu H, Li M, Gao Z, Fan Y, Xu J, Wang H, Wang S, Qiu J, Wang Q, Guo X, Deng L, Zhang P, Xue H, Li G. EWSR1-induced circNEIL3 promotes glioma development and exosome-mediated macrophage immunosuppressive polarization by way of stabilizing IGF2BP3. Mol Most cancers. 2022;21:16.
Vilar JB, Christmann M, Tomicic MT. Alterations in molecular profiles affecting glioblastoma resistance to radiochemotherapy: the place does the nice go? Cancers (Basel). 2022;14:2416.
Janjua TI, Rewatkar P, Ahmed-Cox A, Saeed I, Mansfeld FM, Kulshreshtha R, Kumeria T, Ziegler DS, Kavallaris M, Mazzieri R, Popat A. Frontiers within the therapy of glioblastoma: previous, current and rising. Adv Drug Deliv Rev. 2021;171:108–38.
Dai X, Liao Ok, Zhuang Z, Chen B, Zhou Z, Zhou S, Lin G, Zhang F, Lin Y, Miao Y, Li Z, Huang R, Qiu Y, Lin R. AHIF promotes glioblastoma development and radioresistance by way of exosomes. Int J Oncol. 2019;54:261–70.
Yue X, Lan F, Xia T. Hypoxic glioma cell-secreted exosomal miR-301a prompts Wnt/β-catenin signaling and promotes radiation resistance by focusing on TCEAL7. Mol Ther. 2019;27:1939–49.
Kannan S, Murugan AK, Balasubramanian S, Munirajan AK, Alzahrani AS. Gliomas: genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and up to date tendencies in molecular therapeutic choices. Biochem Pharmacol. 2022;201:115090.
Qiao L, Yang H, Shao XX, Yin Q, Fu XJ, Wei Q. Analysis progress on nanoplatforms and nanotherapeutic methods in treating glioma. Mol Pharm. 2022;19:1927–51.
Aldoghachi AF, Aldoghachi AF, Breyne Ok, Ling KH, Cheah PS. Current advances within the therapeutic methods of glioblastoma multiforme. Neuroscience. 2022;491:240–70.
van Solinge TS, Nieland L, Chiocca EA, Broekman MLD. Advances in native remedy for glioblastoma—taking the combat to the tumour. Nat Rev Neurol. 2022;18:221–36.
Zeng AL, Yan W, Liu YW, Wang Z, Hu Q, Nie E, Zhou X, Li R, Wang XF, Jiang T, You YP. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene. 2017;36:5369–81.
Yang ZJ, Zhang LL, Bi QC, Gan LJ, Wei MJ, Hong T, Tan RJ, Lan XM, Liu LH, Han XJ, Jiang LP. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide. Oncol Rep. 2021;45:44.
Ma C, Nguyen HPT, Jones JJ, Stylli SS, Whitehead CA, Paradiso L, Luwor RB, Areeb Z, Hanssen E, Cho E, Putz U, Kaye AH, Morokoff AP. Extracellular vesicles secreted by glioma stem cells are concerned in radiation resistance and glioma development. Int J Mol Sci. 2022;23:2770.
Wang R, Liang Q, Zhang X, Di Z, Wang X, Di L. Tumor-derived exosomes reversing TMZ resistance by synergistic drug supply for glioma-targeting therapy. Colloids Surf B Biointerfaces. 2022;215:112505.
Wei QT, Liu BY, Ji HY, Lan YF, Tang WH, Zhou J, Zhong XY, Lian CL, Huang QZ, Wang CY, Xu YM, Guo HB. Exosome-mediated switch of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas. Mol Ther Oncolytics. 2021;22:114–28.
Yang JK, Yang JP, Tong J, Jing SY, Fan B, Wang F, Solar GZ, Jiao BH. Exosomal miR-221 targets DNM3 to induce tumor development and temozolomide resistance in glioma. J Neurooncol. 2017;131:255–65.
Zeng A, Wei Z, Yan W, Yin J, Huang X, Zhou X, Li R, Shen F, Wu W, Wang X, You Y. Exosomal switch of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Most cancers Lett. 2018;436:10–21.
He L, Li H, Wu A, Peng Y, Shu G, Yin G. Capabilities of N6-methyladenosine and its function in most cancers. Mol Most cancers. 2019;18:176.
Zhang Z, Yin J, Lu C, Wei Y, Zeng A, You Y. Exosomal switch of lengthy non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma. J Exp Clin Most cancers Res. 2019;38:166.
Wang J, Li T, Wang B. Exosomal switch of miR-25-3p promotes the proliferation and temozolomide resistance of glioblastoma cells by focusing on FBXW7. Int J Oncol. 2021;59:64.
Li Z, Meng X, Wu P, Zha C, Han B, Li L, Solar N, Qi T, Qin J, Zhang Y, Tian Ok, Li S, Yang C, Ren L, Ming J, Wang P, Music Y, Jiang C, Cai J. Glioblastoma cell-derived lncRNA-containing exosomes induce microglia to supply complement C5, selling chemotherapy resistance. Most cancers Immunol Res. 2021;9:1383–99.
Han C, Wang S, Wang H, Zhang J. Exosomal circ-HIPK3 facilitates tumor development and temozolomide resistance by regulating miR-421/ZIC5 axis in glioma. Most cancers Biother Radiopharm. 2021;36:537–48.
Wang X, Cao Q, Shi Y, Wu X, Mi Y, Liu Ok, Kan Q, Fan R, Liu Z, Zhang M. Identification of low-dose radiation-induced exosomal circ-METRN and miR-4709-3p/GRB14/PDGFRα pathway as a key regulatory mechanism in Glioblastoma development and radioresistance: useful validation and medical theranostic significance. Int J Biol Sci. 2021;17:1061–78.
Ding C, Yi X, Chen X, Wu Z, You H, Chen X, Zhang G, Solar Y, Bu X, Wu X, Lin Z, Gu J, Lin Y, Kang D. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression via a number of pathways and enhances temozolomide resistance in glioma. J Exp Clin Most cancers Res. 2021;40:164.
Si J, Li W, Li X, Cao L, Chen Z, Jiang Z. Heparanase confers temozolomide resistance by regulation of exosome secretion and round RNA composition in glioma. Most cancers Sci. 2021;112:3491–506.
Jerabkova-Roda Ok, Dupas A, Osmani N, Hyenne V, Goetz JG. Circulating extracellular vesicles and tumor cells: sticky companions in metastasis. Traits Most cancers. 2022. https://doi.org/10.1016/j.trecan.2022.05.002.
Rehman AU, Khan P, Maurya SK, Siddiqui JA, Santamaria-Barria JA, Batra SK, Nasser MW. Liquid biopsies to occult mind metastasis. Mol Most cancers. 2022;21:113.
Tyagi A, Wu SY, Watabe Ok. Metabolism within the development and metastasis of mind tumors. Most cancers Lett. 2022;539:215713.
Rogiers A, Lobon I, Spain L, Turajlic S. The genetic evolution of metastasis. Most cancers Res. 2022;82:1849–57.
Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, MorenoBueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, et al. Melanoma exosomes educate bone marrow progenitor cells towards a pro-metastatic phenotype via MET. Nat Med. 2012;18:883–91.
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et al. Pancreatic most cancers exosomes provoke pre-metastatic area of interest formation within the liver. Nat Cell Biol. 2015;17:816–26.
Liu Y, Cao X. Traits and significance of the pre-metastatic area of interest. Most cancers Cell. 2016;30:668–81.
Novo D, Heath N, Mitchell L, Caligiuri G, MacFarlane A, Reijmer D, Charlton L, Knight J, Calka M, McGhee E, et al. Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin ranges. Nat Commun. 2018;9:5069.
Cai Q, Zhu A, Gong L. Exosomes of glioma cells ship miR-148a to advertise proliferation and metastasis of glioblastoma by way of focusing on CADM1. Bull Most cancers. 2018;105:643–51.
Bian EB, Chen EF, Xu YD, Yang ZH, Tang F, Ma CC, Wang HL, Zhao B. Exosomal lncRNA-ATB prompts astrocytes that promote glioma cell invasion. Int J Oncol. 2019;54:713–21.
Xu X, Liu Y, Li Y, Chen H, Zhang Y, Liu J, Deng S, Zheng Y, Solar X, Wang J, Chen T, Huang M, Ke Y. Selective exosome exclusion of miR-375 by glioma cells promotes glioma development by activating the CTGF-EGFR pathway. J Exp Clin Most cancers Res. 2021;40:16.
Qian M, Chen Z, Guo X, Wang S, Zhang Z, Qiu W, Qi Y, Zhang S, Xu J, Zhao R, Xue H, Li G. Exosomes derived from hypoxic glioma ship miR-1246 and miR-10b-5p to normoxic glioma cells to advertise migration and invasion. Lab Make investments. 2021;101:612–24.
Han Y, Liu Y, Zhang B, Yin G. Exosomal circRNA 0001445 promotes glioma development via miRNA-127-5p/SNX5 pathway. Getting old (Albany NY). 2021;13:13287–99.
Geindreau M, Bruchard M, Vegran F. Position of cytokines and chemokines in angiogenesis in a tumor context. Cancers (Basel). 2022;14:2446.
Liu J, Zhang Q, Yang D, Xie F, Wang Z. The function of lengthy non-coding RNAs in angiogenesis and anti-angiogenic remedy resistance in most cancers. Mol Ther Nucleic Acids. 2022;28:397–407.
Kumar VBS, Anjali Ok. Tumour generated exosomal miRNAs: a significant participant in tumour angiogenesis. Biochim Biophys Acta Mol Foundation Dis. 2022;1868:166383.
Kasherman L, Liu SL, Karakasis Ok, Lheureux S. Angiogenesis: a pivotal therapeutic goal within the drug growth of gynecologic cancers. Cancers (Basel). 2022;14:1122.
Poto R, Cristinziano L, Modestino L, de Paulis A, Marone G, Loffredo S, Galdiero MR, Varricchi G. Neutrophil extracellular entice,s angiogenesis and most cancers. Biomedicines. 2022;10:431.
Huang M, Lei Y, Zhong Y, Chung C, Wang M, Hu M, Deng L. New insights into the regulatory roles of extracellular vesicles in tumor angiogenesis and their medical implications. Entrance Cell Dev Biol. 2021;9:791882.
Wang Z, Yuan Y, Ji X, Xiao X, Li Z, Yi X, Zhu Y, Guo T, Wang Y, Chen L, Liu Y. The Hippo-TAZ axis mediates vascular endothelial progress issue C in glioblastoma-derived exosomes to advertise angiogenesis. Most cancers Lett. 2021;513:1–13.
Lang HL, Hu GW, Zhang B, Kuang W, Chen Y, Wu L, Xu GH. Glioma cells improve angiogenesis and inhibit endothelial cell apoptosis via the discharge of exosomes that comprise lengthy non-coding RNA CCAT2. Oncol Rep. 2017;38:785–98.
Solar X, Ma X, Wang J, Zhao Y, Wang Y, Bihl JC, Chen Y, Jiang C. Glioma stem cells-derived exosomes promote the angiogenic skill of endothelial cells via miR-21/VEGF sign. Oncotarget. 2017;8:36137–48.
Treps L, Perret R, Edmond S, Ricard D, Gavard J. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A consider extracellular vesicles. J Extracell Vesicles. 2017;6:1359479.
Wang ZF, Liao F, Wu H, Dai J. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma. J Exp Clin Most cancers Res. 2019;38:201.
Li J, Yuan H, Xu H, Zhao H, Xiong N. Hypoxic cancer-secreted exosomal miR-182-5p promotes glioblastoma angiogenesis by focusing on Kruppel-like Issue 2 and 4. Mol Most cancers Res. 2020;18:1218–31.
Wang M, Zhao Y, Yu ZY, Zhang RD, Li SA, Zhang P, Shan TK, Liu XY, Wang ZM, Zhao PC, Solar HW. Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis via activating the EGFR/MAPK signaling pathway by way of inhibiting ERRFI1. Most cancers Cell Int. 2020;20:518.
Jiang J, Lu J, Wang X, Solar B, Liu X, Ding Y, Gao G. Glioma stem cell-derived exosomal miR-944 reduces glioma progress and angiogenesis by inhibiting AKT/ERK signaling. Getting old (Albany NY). 2021;13:19243–59.
Li Y, Chen J, Chen Z, Xu X, Weng J, Zhang Y, Mo Y, Liu Y, Wang J, Ke Y. CircGLIS3 promotes high-grade glioma invasion by way of modulating ezrin phosphorylation. Entrance Cell Dev Biol. 2021;9:663207.
Solar Z, Wang L, Zhou Y, Dong L, Ma W, Lv L, Zhang J, Wang X. Glioblastoma stem cell-derived exosomes improve stemness and tumorigenicity of glioma cells by transferring notch1 protein. Cell Mol Neurobiol. 2020;40:767–84.
Li J, Liao T, Liu H, Yuan H, Ouyang T, Wang J, Chai S, Li J, Chen J, Li X, Zhao H, Xiong N. Hypoxic glioma stem cell-derived exosomes containing Linc01060 promote development of glioma by regulating the MZF1/c-Myc/HIF1α axis. Most cancers Res. 2021;81:114–28.
Chai Y, Wu HT, Liang CD, You CY, Xie MX, Xiao SW. Exosomal lncRNA ROR1-AS1 derived from tumor cells promotes glioma development by way of regulating miR-4686. Int J Nanomed. 2020;15:8863–72.
Ding C, Yi X, Wu X, Bu X, Wang D, Wu Z, Zhang G, Gu J, Kang D. Exosome-mediated switch of circRNA CircNFIX enhances temozolomide resistance in glioma. Most cancers Lett. 2020;479:1–12.
Li X, Li X, Zhang B, He B. The function of most cancers stem cell-derived exosomes in most cancers development. Stem Cells Int. 2022;2022:9133658.
Jin Y, Du N, Huang Y, Shen W, Tan Y, Chen YZ, Dou WT, He XP, Yang Z, Xu N, Tan C. Fluorescence evaluation of circulating exosomes for breast most cancers analysis utilizing a sensor array and deep studying. ACS Sens. 2022;7:1524–32.
Du S, Qian J, Tan S, Li W, Liu P, Zhao J, Zeng Y, Xu L, Wang Z, Cai J. Tumor cell-derived exosomes ship TIE2 protein to macrophages to advertise angiogenesis in cervical most cancers. Most cancers Lett. 2022;529:168–79.
Oey O, Ghaffari M, Li JJ, Hosseini-Beheshti E. Software of extracellular vesicles within the analysis and therapy of prostate most cancers: Implications for medical observe. Crit Rev Oncol Hematol. 2021;167:103495.
Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, Fu W, Yi J, Wang J, Du G. The biology, perform, and functions of exosomes in most cancers. Acta Pharm Sin B. 2021;11:2783–97.
Chen SW, Zhu SQ, Pei X, Qiu BQ, Xiong D, Lengthy X, Lin Ok, Lu F, Xu JJ, Wu YB. Most cancers cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC. Mol Most cancers. 2021;20:144.
Lin Y, Zheng ZH, Wang JX, Zhao Z, Peng TY. Tumor cell-derived exosomal Circ-0072088 suppresses migration and invasion of hepatic carcinoma cells via regulating MMP-16. Entrance Cell Dev Biol. 2021;9:726323.
Wang C, Huang CH, Gao Z, Shen J, He J, MacLachlan A, Ma C, Chang Y, Yang W, Cai Y, Lou Y, Dai S, Chen W, Li F, Chen P. Nanoplasmonic sandwich immunoassay for tumor-derived exosome detection and exosomal PD-L1 profiling. ACS Sens. 2021;6:3308–19.
Yu Z, Lin S, Xia F, Liu Y, Zhang D, Wang F, Wang Y, Li Q, Niu J, Cao C, Cui D, Sheng N, Ren J, Wang Z, Chen D. ExoSD chips for high-purity immunomagnetic separation and high-sensitivity detection of gastric most cancers cell-derived exosomes. Biosens Bioelectron. 2021;194:113594.
He R, Wang Z, Shi W, Yu L, Xia H, Huang Z, Liu S, Zhao X, Xu Y, Yam JWP, Cui Y. Exosomes in hepatocellular carcinoma microenvironment and their potential medical software worth. Biomed Pharmacother. 2021;138:111529.
Yuan X, Qian N, Ling S, Li Y, Solar W, Li J, Du R, Zhong G, Liu C, Yu G, Cao D, Liu Z, Wang Y, Qi Z, Yao Y, Wang F, Liu J, Hao S, Jin X, Zhao Y, Xue J, Zhao D, Gao X, Liang S, Li Y, Music J, Yu S, Li Y. Breast most cancers exosomes contribute to pre-metastatic area of interest formation and promote bone metastasis of tumor cells. Theranostics. 2021;11:1429–45.
Lin B, Tian T, Lu Y, Liu D, Huang M, Zhu L, Zhu Z, Music Y, Yang C. Tracing Tumor-derived exosomal PD-L1 by dual-aptamer activated proximity-induced droplet digital PCR. Angew Chem Int Ed Engl. 2021;60:7582–6.
Qiu Y, Yang Y, Yang R, Liu C, Hsu JM, Jiang Z, Solar L, Wei Y, Li CW, Yu D, Zhang J, Hung MC. Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast most cancers. Oncogene. 2021;40:4992–5001.
Xiong H, Huang Z, Yang Z, Lin Q, Yang B, Fang X, Liu B, Chen H, Kong J. Current progress in detection and profiling of most cancers cell-derived exosomes. Small. 2021;17:e2007971.
Lin L, Wang H, Guo W, He E, Huang Ok, Zhao Q. Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss. Cell Sign. 2021;82:109935.
Chen F, Xu B, Li J, Yang X, Gu J, Yao X, Solar X. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma by way of KLF10. J Exp Clin Most cancers Res. 2021;40:38.
Jing B, Gai Y, Qian R, Liu Z, Zhu Z, Gao Y, Lan X, An R. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon most cancers. J Nanobiotechnol. 2021;19:7.
Ma Z, Cui X, Lu L, Chen G, Yang Y, Hu Y, Lu Y, Cao Z, Wang Y, Wang X. Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis. Stem Cell Res Ther. 2019;10:60.
Yin J, Zeng A, Zhang Z, Shi Z, Yan W, You Y. Exosomal switch of miR-1238 contributes to temozolomide-resistance in glioblastoma. EBioMedicine. 2019;42:238–51.
